Miacalcin Logo
  Novartis Pharma US

 



MIACALCIN Home
Healthcare Professionals
Professional Main Page
Treatment Guidelines
MIACALCIN Nasal Spray
Patient Challenges
Patient Education
Resources
 
Clinical & Scientific References
Medical & Professional Links
Events
Prescribing Information


Novartis Medicare Resource Center

Tools
Clinical Information
Dosing & Administration
Clinical & Scientific References


Access clinical and scientific information about MIACALCIN® (calcitonin-salmon) Nasal Spray.

View the reading of your choice. Simply click on the reference title.

Ellerington MC, Hillard TC, Whitcroft SIJ, et al. Intranasal salmon calcitonin for the prevention and treatment of postmenopausal osteoporosis. Calcif Tissue Int. 1996;59:6-11.
 
Overgaard K, Hansen MA, Jensen SB, et al. Effect of salmon calcitonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study. BMJ. 1992;305:556-561.
 
Overgaard K, Lindsay R, Christiansen C. Patient responsiveness to calcitonin salmon nasal spray: a subanalysis of a 2-year study. Clin Ther. 1995;17:680-685.
 
Overgaard K, Riis BJ, Christiansen C, et al. Nasal calcitonin for treatment of established osteoporosis. Clin Endocrinol. 1989;30:435-442.


Home | Professional Main Page | Treatment Guidelines
MIACALCIN Nasal Spray | Patient Challenges | Patient Education
Resources | Prescribing Information



Novartis Pharma US Use of website is governed by the Terms of Use and Privacy Statement .
Copyright ©2008
Novartis Pharmaceuticals Corporation. All rights reserved.

Novartis proudly supports the Together Rx Access program.
Together Rx Access